Virtual healthcare services, or telehealth, are rapidly becoming a standard of care in the expanding digital healthcare space ...

Novo Nordisk just killed its deal with Hims & Hers. But Hims might come out stronger after this development. Read why the ...

In a grassy outcrop along Lake Michigan’s deep blue waters, two young men pictured in a color slide photograph relax on towels, shirtless and curled against each other. Along the rocky ledges, other ...

HIMS' Price Performance, Valuation and Estimates Shares of Hims & Hers have surged 121.7% year to date compared with the industry ’s gain of 22.9%. Image Source: Zacks Investment Research ...

Hims & Hers is also planning to introduce a new, personalized dimension of digital health in Europe. Through this, the company aims to provide individuals with access to care tailored to their ...

Should you buy HIMS stock at $57?Lofty Valuations HIMS stock is deemed expensive by most metrics. The company trades at 6.6 times its sales, which is more than double the S&P 500’s 3.0 ratio ...

Comparing EPS Projections: Hims & Hers & Amwell The Zacks Consensus Estimate for HIMS’ 2025 earnings per share suggests a 166.7% improvement from 2024. Image Source: Zacks Investment Research ...

Shares of Hims & Hers soared $4.21, or 29%, to $18.79 in Monday afternoon trading. GLP-1 drugs, which stands for glucagon-like peptide 1 agonists, help people feel fuller and less hungry, aiding ...

Hims & Hers Health (NYSE:HIMS) reported first-quarter earnings on Monday after the market closed and rocketed 18% after revenue more than doubled, and it raised full-year guidance. Revenue hit ...

Hims & Hers Health (NYSE:HIMS) reported a strong financial performance for Q1 2025, with revenue reaching $586 million, marking a 111% increase year-over-year. The company achieved a net income of ...

Shares of Hims & Hers Health (HIMS 6.81%) and LifeMD (LFMD 1.55%) are surging on Tuesday. The companie' stocks had jumped 24% and 34%, respectively, as of 3:15 p.m. ET as the S&P 500 and the ...